Drug-target residence time and its implications for lead optimization
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their macromolecular targets is therefore seen as paramount for pharmacological activity. In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC(50) or K(d). This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex. We describe the potential advantages of long residence time in terms of duration of pharmacological effect and target selectivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translation between slow inhibitor binding kinetics and sustained pharmacodynamic modulation has been studied for a numberoftarget classes (58).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [58]
In the citing paper
“Furthermore, the targets of infectious diseases usually have high replication rates, while covalent inhibitors tend to have long residence times making them less effective in this area [128].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [128]
In the citing paper
“Furthermore, longer residence times of drugs with their targets, as a result of slower off-rates, is a useful mechanism to extend in-vivo efficacy (59–61).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [59]
Citations
Cites
Catalysis in chemistry and enzymology
Jencks, W. P. (1969) · Medical Entomology and Zoology · Cited by 3,217
Structure and Mechanism in Protein Science
Fersht, A. (1998) · Cited by 1,882
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Self-citationLiang, J., Woodward, C., & Edelsbrunner, H. (1998) · Protein Science · doi:10.1002/pro.5560070905 · Cited by 1,057
Enzymes: a practical introduction to structure, mechanism, and data analysis
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3881 · Cited by 1,056
Optical biosensors in drug discovery
Cooper, M. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd838 · Cited by 1,015
Oppenheimer, N. J., & James, T. L. (1989) · Academic Press eBooks · Cited by 820
Rusnak, D. W., Lackey, K. E., Affleck, K., Wood, E. R., Alligood, K. J., Rhodes, N., Keith, B. R., Murray, D. M., Knight, W. B., Mullin, R. J., et al. (2001) · PubMed · Cited by 728
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
Copeland, R. A. (2000) · Wiley eBooks · doi:10.1002/0471220639 · Cited by 726
Self-citation
Cited by
Items 801–900 of 1,003
Zaghouani, M., Bögeholz, L. A. K., Mercier, E., Wintermeyer, W., & Roche, S. P. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.03.037 · Cited by 15
Peeking at G-protein-coupled Receptors Through the Molecular Dynamics Keyhole
Deganutti, G., Moro, S., & Reynolds, C. A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0393 · Cited by 17
Fischer, O., Hofmann, J., Rampp, H., Kaindl, J. M., Pratsch, G., Bartuschat, A. L., Taudte, R. V., Fromm, M. F., Hübner, H., Gmeiner, P., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00297 · Cited by 15
Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation
Vendruscolo, M. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2221024 · Cited by 16
Learning Protein–Ligand Unbinding Pathways via Single-Parameter Community Detection
Tänzel, V., Jäger, M., & Wolf, S. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c00250 · Cited by 19
Insights into Ligand–Protein Binding from Local Mechanical Response
Patel, J. S., Branduardi, D., Masetti, M., Rocchia, W., & Cavalli, A. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct200324j · Cited by 15
Binding properties of antagonists to Cannabinoid receptors in intact cells
Wennerberg, M., Cheng, L., Hjorth, S., Clapham, J. C., Balendran, A., & Vauquelin, G. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00843.x · Cited by 15
Enhanced Sampling Methods in Drug Design
Rocchia, W., Masetti, M., & Cavalli, A. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735377-00273 · Cited by 15
Working with Small Molecules: Rules-of-Thumb of “Drug Likeness”
Zhang, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-364-6_20 · Cited by 19
Booe, J. M., Warner, M. L., & Pioszak, A. A. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00031 · Cited by 15
Kumar, V., & Sobhia, M. E. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.27 · Cited by 15
Kohout, T. A., Xie, Q., Reijmers, S., Finn, K. J., Guo, Z., Zhu, Y., & Struthers, R. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035535 · Cited by 15
Malherbe, P., Kratzeisen, C., Marcuz, A., Zenner, M., Nettekoven, M. H., Ratni, H., Wettstein, J. G., & Bissantz, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900948q · Cited by 15
SIGLEC-4 (MAG) antagonists: From the natural carbohydrate epitope to glycomimetics
Schwardt, O., Kelm, S., & Ernst, B. (2013) · Topics in current chemistry · doi:10.1007/128_2013_498 · Cited by 14
Bilayer lipids modulate ligand binding to atypical chemokine receptor 3
Eberle, S. A., & Gustavsson, M. (2024) · Structure · doi:10.1016/j.str.2024.04.018 · Cited by 16
High-throughput kinetics in drug discovery
Pinto, M. F., Sirina, J., Holliday, N. D., & McWhirter, C. L. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.100170 · Cited by 16
Emerging magic bullet: subcellular organelle-targeted cancer therapy
Yan, Y., Zhang, Y., Liu, J., Chen, B., & Wang, Y. (2024) · Medical Review · doi:10.1515/mr-2024-0044 · Cited by 18
Pawlędzio, S., Ziemniak, M., Wang, X., Woźniak, K., & Malińska, M. (2025) · IUCrJ · doi:10.1107/s2052252525000053 · Cited by 15
Meini, S., Bellucci, F., Catalani, C., Cucchi, P., Giolitti, A., Giuliani, S., Quartara, L., Rotondaro, L., Zappitelli, S., & Maggi, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01133.x · Cited by 14
Copeland, R. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1831 · Cited by 14
Self-citationZhen, J., Antonio, T., Ali, S., Neve, K. A., Dutta, A. K., & Reith, M. E. A. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.03.028 · Cited by 14
Zhou, X., Huntjens, D., & Gilissen, R. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12035 · Cited by 14
Иорданский, А. Л., Zhulkina, A., Olkhov, A. A., Fomin, S. V., Burkov, A. A., & Stilman, M. (2018) · Polymers · doi:10.3390/polym10080817 · Cited by 14
Dissecting the Protein Dynamics Coupled Ligand Binding with Kinetic Models and Single-Molecule FRET
Wu, S., Zhang, W., Li, W., Huang, W., Kong, Q., Chen, Z., Wei, W., & Yan, S. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00771 · Cited by 14
Yao, B., Yang, Y., Yu, N., Tao, N. J., Wang, D., Wang, S., & Zhang, F. (2022) · Small · doi:10.1002/smll.202201623 · Cited by 14
Simulation of ligand dissociation kinetics from the protein kinase PYK2
Spiriti, J. M., Noé, F., & Wong, C. F. (2022) · Journal of Computational Chemistry · doi:10.1002/jcc.26991 · Cited by 14
Rossetti, T., Ferreira, J., Ghanem, L., Buck, H., Steegborn, C., Myers, R. W., Meinke, P. T., Levin, L. R., & Buck, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1013845 · Cited by 14
Stampelou, M., Ladds, G., & Kolocouris, A. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c05986 · Cited by 15
Development of a Targeted Gene Vector Platform Based on Simian Adenovirus Serotype 24
Belousova, N., Mikheeva, G., Xiong, C., Soghomonian, S., Young, D. P., Roux, L. L., Naff, K. A., Bidaut, L. M., Wei, W., Li, C., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02425-09 · Cited by 14
Niu, Y., Pan, D., Yang, Y., Liu, H., & Yao, X. (2016) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2016.08.002 · Cited by 14
Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury
Gao, M., Zhang, H. M., Trivedi, A. A., Mahasenan, K. V., Schroeder, V. A., Wolter, W. R., Suckow, M. A., Mobashery, S., Noble‐Haeusslein, L. J., & Chang, M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00217 · Cited by 14
Towards Improved Oligonucleotide Therapeutics Through Faster Target Binding Kinetics
Menzi, M., Wild, B., Pradère, U., Malinowska, A. L., Brunschweiger, A., Lightfoot, H. L., & Hall, J. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701670 · Cited by 14
Receptor binding kinetics equations: Derivation using the Laplace transform method
Hoare, S. R. J. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.08.004 · Cited by 14
Wang, Y., Edalji, R. P., Panchal, S. C., Sun, C. C., Djurić, S. W., & Vasudevan, A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00576 · Cited by 15
Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers
Sakai, Y., Kawaguchi, A., Nagata, K., & Hirokawa, T. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12561 · Cited by 14
Uematsu, S., Tabuchi, Y., Ito, Y., & Taki, M. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00301 · Cited by 14
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2
ElSawy, K. M., Sim, A. Y. L., Lane, D. P., Verma, C. S., & Caves, L. S. D. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989043 · Cited by 14
Friemel, A., Ebert, B., Hutson, P. H., Brust, P., Nieber, K., & Deuther‐Conrad, W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.031 · Cited by 14
A human transcription factor in search mode
Hauser, K., Essuman, B., He, Y., Coutsias, E. A., García–Díaz, M., & Simmerling, C. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1091 · Cited by 14
Roatsch, M., Vogelmann, A., Herp, D., Jung, M., & Olsen, C. A. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12416303.v1 · Cited by 16
Votapka, L. W., Ojha, A. A., Asada, N., & Amaro, R. E. (2024) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.4c02332 · Cited by 15
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9
Daniels, M. H., Castro, J., Lee, Y., Gotur, D., Knockenhauer, K. E., Grigoriu, S., Lockbaum, G. J., Cheong, J. E., Lu, C., Brennan, D., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00252 · Cited by 14
Self-citationSelvaggio, G., & Pearlstein, R. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202376 · Cited by 13
Du, Y., & Wang, R. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00342 · Cited by 15
Kang, D., Liu, Y., Song, Y., Fang, B., Zhang, Q., & Hu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.811850 · Cited by 13
Wheeler, S., & Butler, S. J. (2022) · Analysis & Sensing · doi:10.1002/anse.202200036 · Cited by 14
Allosteric binding cooperativity in a kinetic context
Díaz, Ó., Martı́n, V. S., Renault, P., Romero, D., Guillamon, A., & Giraldo, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103441 · Cited by 13
Prasetiya, F. S., Destiarani, W., Nuwarda, R. F., Rohmatulloh, F. G., Natalia, W., Novianti, M. T., Ramdani, T., Agung, M. U. K., Arsad, S., Sari, L. A., et al. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.102533 · Cited by 13
Purification of Stabilized GPCRs for Structural and Biophysical Analyses
Errey, J. C., Dore, A. S., Zhukov, A., Marshall, F. H., & Cooke, R. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2914-6_1 · Cited by 13
Arcari, J. T., BEEBE, J. S., Berliner, M. A., Bernardo, V., Boehm, M., Borzillo, G. V., Clark, T. H., Cohen, B. D., Connell, R. D., Frost, H. N., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.012 · Cited by 13
Vauquelin, G., Bricca, G., & Liefde, I. V. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12052 · Cited by 13
Ge, Y., Zhang, S., Erdélyi, M., & Voelz, V. A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00029 · Cited by 14
New perspectives in cancer drug development: computational advances with an eye to design
Castelli, M., Serapian, S. A., Marchetti, F., Triveri, A., Pirota, V., Torielli, L., Collina, S., Doria, F., Freccero, M., & Colombo, G. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00192b · Cited by 13
Trends and challenges in microfluidic methods for protein manipulation—A review
Santos-Ramírez, J. M. D. L., Boyas‐Chavez, P. G., Cerrillos‐Ordoñez, A., Mata‐Gómez, M. A., Gallo‐Villanueva, R. C., & Pérez‐González, V. H. (2023) · Electrophoresis · doi:10.1002/elps.202300056 · Cited by 14
Structure-guided residence time optimization of a dabigatran reversal agent
Schiele, F., van Ryn, J., Litzenburger, T., Ritter, M. A., Seeliger, D., & Nar, H. (2015) · mAbs · doi:10.1080/19420862.2015.1057364 · Cited by 13
Public–Private Partnerships in Lead Discovery: Overview and Case Studies
Gottwald, M., Becker, A., Bahr, I., & Mueller‐Fahrnow, A. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201600078 · Cited by 13
Costa, B., Taliani, S., Pozzo, E. D., Barresi, E., Robello, M., Cavallini, C., Cosconati, S., Settimo, F. D., Novellino, E., & Martini, C. (2017) · ChemMedChem · doi:10.1002/cmdc.201700220 · Cited by 13
Dihydrosanguinarine Enhances Glucose Uptake in Mouse 3T3-L1 Cells
Chow, Y., Iwata, Y., & Sato, F. (2017) · ACS Omega · doi:10.1021/acsomega.7b01134 · Cited by 13
Huang, S., Chen, L., Hu, M. Y., Zhang, D., Shi, T., Kuang, Z., Heng, Y., Xu, L., & Pan, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072456 · Cited by 13
Predicting Selectivity and Druggability in Drug Discovery
Cheng, A. C. (2008) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(08)00002-9 · Cited by 13
Erratum: Drug–target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2281 · Cited by 13
Self-citationSharma, S., Joshi, S., Kalidindi, T. M., Digwal, C. S., Panchal, P., Lee, S., ZANZONICO, P. B., Pillarsetty, N., & Chiosis, G. (2023) · Biomedicines · doi:10.3390/biomedicines11102599 · Cited by 13
Khaoua, O., Guenfoud, F., Benbellat, N., Chelaghma, W., Loucif, L., Boussebaa, W., & Messaoudi, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143849 · Cited by 12
Kinetic Insights into the Binding between the nSH3 Domain of CrkII and Proline-Rich Motifs in cAbl
Zeng, D., Bhatt, V. S., Shen, Q., & Cho, J. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.09.029 · Cited by 13
Spiegelberg, D., Stenberg, J., Richalet-Sécordel, P. M., & Vanhove, M. (2021) · European Biophysics Journal · doi:10.1007/s00249-021-01560-2 · Cited by 12
Chen, H., Zhou, R., Pang, J., Guo, Y., Chen, J. C., Kang, Y., Duan, M., & Hou, T. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00150 · Cited by 12
Koneru, J. K., Sinha, S., & Mondal, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101271 · Cited by 12
Lindgren, C., Forsgren, N., Hoster, N., Akfur, C., Artursson, E., Edvinsson, L., Svensson, R., Worek, F., Ekström, F., & Linusson, A. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202200678 · Cited by 12
Pesaresi, A., Lamba, D., Vezenkov, L. T., Tsekova, D. S., & Lozanov, V. S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110092 · Cited by 13
Binding and Unbinding Pathways of Peptide Substrates on the SARS-CoV-2 3CL Protease
Moritsugu, K., Ekimoto, T., Ikeguchi, M., & Kidera, A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00946 · Cited by 12
Herold, R. A., Schofield, C. J., & Armstrong, F. A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309149 · Cited by 13
Xiang, S., Wang, Z., Tang, R., Wang, L., Wang, Q., Yu, Y., Deng, Q., Hou, T., Hao, H., & Sun, H. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01451 · Cited by 12
Computational Approaches for Studying Drug Binding Kinetics
Romanowska, J., Kokh, D. B., Fuller, J. C., & Wade, R. C. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673025.ch11 · Cited by 14
Inhaled drug therapy development for the treatment of migraine
Chua, A. L., & Silberstein, S. D. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1203901 · Cited by 12
Castañeda, C. H., Scuderi, M. J., Edwards, T. G., Harris, G. D., Dupureur, C. M., Koeller, K. J., Fisher, C., & Bashkin, J. K. (2016) · MedChemComm · doi:10.1039/c6md00371k · Cited by 12
Kinetics-Based Structural Requirements of Human Immunoglobulin G Binding Peptides
Muguruma, K., Fujita, K., Fukuda, A., Kishimoto, S., Sakamoto, S., Arima, R., Ito, M., Kawasaki, M., Nakano, S., Ito, S., et al. (2019) · ACS Omega · doi:10.1021/acsomega.9b01104 · Cited by 13
On the Hill relation and the mean reaction time for metastable processes
Baudel, M., Guyader, A., & Tony Lelièvre, A. (2022) · Stochastic Processes and their Applications · doi:10.1016/j.spa.2022.10.014 · Cited by 12
Warhead Reactivity Limits the Speed of Inhibition of the Cysteine Protease Rhodesain
Johé, P., Jung, S., Endres, E., Kersten, C., Zimmer, C., Ye, W., Sönnichsen, C., Hellmich, U. A., Sotriffer, C., Schirmeister, T., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00911 · Cited by 13
Identifying requirements for RSK2 specific inhibitors
Wright, E. B., Fukuda, S., Li, M., Li, Y., O'Doherty, G. A., & Lannigan, D. A. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1957862 · Cited by 14
Meini, S., Bellucci, F., Catalani, C., Cucchi, P., Giolitti, A., Santicioli, P., & Giuliani, S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150201 · Cited by 12
Distinct in vivo target occupancy by bivalent‐ and induced‐fit‐like binding drugs
Vauquelin, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13989 · Cited by 12
Koneru, J. K., Sinha, S., & Mondal, J. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b02883 · Cited by 13
Mocking, T. A. M., Buzink, M. C. M. L., Leurs, R., & Vischer, H. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153724 · Cited by 12
Norval, L., Krämer, S. D., Gao, M., Herz, T., Li, J., Rath, C., Wöhrle, J., Günther, S., & Roth, G. D. (2019) · Database · doi:10.1093/database/baz101 · Cited by 12
Lee, Y., Choi, J., Yoon, Y. J., Sim, Y., Ryu, H. W., Oh, S., Kim, D., Hwang, J.-H., Chi, S., Han, D. C., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6918 · Cited by 12
Voss, J. H., Crüsemann, M., Bartling, C. R. O., Kehraus, S., Inoue, A., König, G. M., Strømgaard, K., & Müller, C. E. (2022) · iScience · doi:10.1016/j.isci.2023.106492 · Cited by 11
Khan, Z. R., Welsby, P. J., Stasik, I., & Hayes, J. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00373 · Cited by 12
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18070951 · Cited by 13
Muñiz‐Chicharro, A., Ganotra, G. K., & Wade, R. C. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01488 · Cited by 13
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
Qiao, H., Yuan, Z., Xing, L., He, B., Ma, L., & He, Z. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02299 · Cited by 11
Hong, S.-S., & Lim, S. (2014) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-014-0146-z · Cited by 11
Binding Interaction of Organofluorine–Serum Albumin: A Comparative Ligand-Detected19F NMR Analysis
Chaubey, B., & Pal, S. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b06583 · Cited by 11
Toward in vivo relevant drug design
Pearlstein, R. A., Wan, H., & Aravamuthan, V. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.012 · Cited by 11
Khurana, P., McWilliams, L. J., Wingfield, J. M., Barratt, D. G., & Srinivasan, B. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211000676 · Cited by 11
Basu, R., Wang, N., Basak, S., Daryaee, F., Babar, M., Allen, E. K. H., Walker, S. G., Haley, J. D., & Tonge, P. J. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00317 · Cited by 12
Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials
Bobrovs, R., Basens, E. E., Drunka, L., Kanepe, I., Matisone, S., Velins, K. K., Andrianov, V. G., Leitis, G., Zelencova-Gopejenko, D., Rasiņa, D., et al. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00422 · Cited by 11
pH Regulates Ligand Binding to an Enzyme Active Site by Modulating Intermediate Populations
Singh, K., Muttathukattil, A. N., Singh, P. C., & Reddy, G. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c05117 · Cited by 12
Shapiro, A. B., Gao, N., Hajec, L. I., & McKinney, D. C. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.08.024 · Cited by 11
Perspectives on drug discovery strategies based on IDPs
Fuertes, G., Nevola, L., & Esteban-Martín, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816348-1.00009-0 · Cited by 15
Schiedel, M., Daub, H., Itzen, A., & Jung, M. (2019) · ChemBioChem · doi:10.1002/cbic.201900527 · Cited by 11
Metadata
- Authors
- Copeland, R. A., Pompliano, D. L., & Meek, T. D.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Copeland, Robert A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-08-04
- Volume
- 5
- Issue
- 9
- Pages
- 730-739
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2016408686
- Semantic Scholar
- 362824beb2008831aa65b4eb774e5c8703ff9c71
- Cited by
- 1,464
- References
- 46
- Citations by year
- 2026: 83 · 2025: 64 · 2024: 78 · 2023: 79 · 2022: 81 · 2021: 76 · 2020: 83 · 2019: 88 · 2018: 102 · 2017: 104 · 2016: 96 · 2015: 120 · 2014: 74 · 2013: 88 · 2012: 65
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- drug-target residence time, lead optimization, drug selectivity, drug-target binding, binding affinity
- MeSH terms
- Binding, Competitive, Pharmaceutical Preparations, Humans, Kinetics, Ligands, Technology, Pharmaceutical, Drug Design, Drug Delivery Systems, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.